level-one heading

プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Jason C.に依頼

United States

プロフィール概要

I am a PhD scientist with over 15 years of laboratory research experience. I have authored dozens of scientific journal manuscripts, blog articles, book chapters and grant submissions internationally and domestic (US). I have also served as a manuscript reviewer for several scientific journals. My expertise ranges within the fields of biotech & pharmaceutical drug development, academic & industrial research, with an oncology emphasis.

専門分野

• ☆ Science Education
• ☆ Pharmaceutical Sciences
• ☆ Drug Development
• ☆ Oncology
• ☆ Technical & Scientific Writing

サービス

• Writing
• Consulting
• Product Development

職務経験

Postdoctoral Associate

University of Texas MD Anderson Cancer Center

3月 2012 - 現在

PhD Associate

Clark Atlanta University

1月 2007 - 12月 2011

学歴

PhD/ Molecular Biology (Biological Sciences)

Clark Atlanta University

1月 2007 - 12月 2011

B.S. (Biological Sciences)

Clark Atlanta University

8月 2001 - 5月 2005

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

(2017). AXL inhibition suppresses the DNA damage response and sensitizes cells to PARP inhibition in multiple cancers . Molecular Cancer Research. 15. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 45-58.

(2017). Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer . Oncotarget. 8. (9). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 14897-14911.

(2016). PKCiota promotes ovarian tumor progression through deregulation of cyclin e . Oncogene. 35. (19). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 2428-2440.

(2016). Targeting the Cell Cycle in Breast Cancer . Breast Diseases. 27. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 256-260.

(2015). Inhibitor of differentiation 4 (ID4): From development to cancer . Biochimica et Biophysica Acta - Reviews on Cancer. 1855. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 92-103.

(2013). Id4 promotes senescence and sensitivity to doxorubicin-induced apoptosis in DU145 prostate cancer cells . Anticancer Research. 33. (10). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 4271-4278.

(2009). Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer . BMC Cancer. 9.

(2007). Id1-, Id2-, and Id3-regulated gene expression in E2A positive or negative prostate cancer cells . Prostate. 67. (13). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1411-1420.